Tofacitinib does not affect platelet function or coagulation in patients with ulcerative colitis
BackgroundTofacitinib is a Janus kinase inhibitor used to treat inflammatory diseases, including rheumatoid arthritis and ulcerative colitis (UC). Previous studies have reported an increased risk of thromboembolic events in patients with rheumatoid art…